Clinical Trial Update: Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial) [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial evaluating irinotecan in combination with a CDC2-like kinase inhibitor (the SLICK trial) for small cell lung cancer, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CDC2-like kinase inhibitor
• Irinotecan (Irinotecan)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Small-cell Lung Cancer, Small Cell Lung Carcinoma | Phase 1, Phase 2 | Status: RECRUITING